Q4 2024 · 13F-HR
DAFNA Capital Management LLCholdings as filed
Filed 2025-02-14 · accession 0001389932-25-000004
$393.4M
Reported value
82
Positions
2024-12-31
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 78464A870 | XBI | SPDR S&P BIOTECH ETF | $35.8M | 9.10% | 397,505 | Common | SOLE |
| 85916J409 | STXS | STEREOTAXIS INC | $31.2M | 7.93% | 13,680,554 | Common | SOLE |
| 76155X100 | RVMD | REVOLUTION MEDICINES INC | $27.6M | 7.02% | 631,176 | Common | SOLE |
| 04963C209 | ATRC | ATRICURE INC | $19.6M | 4.98% | 641,673 | Common | SOLE |
| N5749R100 | 2GH | MERUS N V | $19.0M | 4.83% | 451,804 | Common | SOLE |
| 23282W605 | CYTK | CYTOKINETICS INC | $18.7M | 4.76% | 398,100 | Common | SOLE |
| 04351P101 | ASNDUSD | ASCENDIS PHARMA A/S | $14.2M | 3.62% | 103,355 | Common | SOLE |
| 05463X106 | AXGN | AXOGEN INC | $14.0M | 3.55% | 846,882 | Common | SOLE |
| 464287556 | IBB | ISHARES NASDAQ BIOTECH INDX | $13.6M | 3.44% | 102,500 | Common | SOLE |
| 09627Y109 | 2655787D | BLUEPRINT MEDICINES CORP | $13.1M | 3.32% | 149,763 | Common | SOLE |
| 45166A102 | IDYA | IDEAYA BIOSCIENCES INC | $12.8M | 3.26% | 498,827 | Common | SOLE |
| 98420N105 | XENE | XENON PHARMACEUTICALS INC | $10.7M | 2.73% | 273,739 | Common | SOLE |
| 64125C109 | NBIX | NEUROCRINE BIOSCIENCES INC | $9.8M | 2.48% | 71,615 | Common | SOLE |
| 23954D109 | DAWNGBX | DAY ONE BIOPHARMACEUTICALS I | $9.3M | 2.36% | 731,363 | Common | SOLE |
| G1110E107 | BHVN | BIOHAVEN LTD | $8.2M | 2.09% | 220,235 | Common | SOLE |
| 875372203 | TNDM | TANDEM DIABETES CARE INC | $8.0M | 2.04% | 223,208 | Common | SOLE |
| 87164F105 | SNDX | SYNDAX PHARMACEUTICALS INC | $7.2M | 1.82% | 542,002 | Common | SOLE |
| 483497103 | KALV | KALVISTA PHARMACEUTICALS INC | $6.9M | 1.75% | 811,678 | Common | SOLE |
| M96088105 | URGN | UROGEN PHARMA LTD | $5.2M | 1.33% | 492,515 | Common | SOLE |
| 252131107 | DXCM | DEXCOM INC | $5.1M | 1.30% | 65,552 | Common | SOLE |
| 09058V103 | BCRX | BIOCRYST PHARMACEUTICALS INC | $5.0M | 1.27% | 667,000 | Common | SOLE |
| 28036F105 | EWTX | EDGEWISE THERAPEUTICS INC | $5.0M | 1.27% | 187,140 | Common | SOLE |
| 04351PAD3 | ASND 2.25 04/01/28 | ASCENDIS PHARMA A/S | $4.4M | 1.12% | 4,000,000 | Common | SOLE |
| 872381108 | TELA | TELA BIO INC | $4.4M | 1.11% | 1,441,029 | Common | SOLE |
| N71542109 | PRQR | PROQR THERAPEUTICS N V | $4.2M | 1.06% | 1,567,561 | Common | SOLE |
| 50127T109 | KURA | KURA ONCOLOGY INC | $3.9M | 0.99% | 448,368 | Common | SOLE |
| 03969F109 | RCUS | ARCUS BIOSCIENCES INC | $3.8M | 0.96% | 254,217 | Common | SOLE |
| 36315X101 | LKFT | GALAPAGOS NV | $3.6M | 0.91% | 130,175 | Common | SOLE |
| G01767105 | ALKS | ALKERMES PLC | $3.5M | 0.88% | 120,700 | Common | SOLE |
| 45784P101 | PODD | INSULET CORP | $3.2M | 0.82% | 12,400 | Common | SOLE |
| 04635X102 | CATBUSD | ASTRIA THERAPEUTICS INC | $2.7M | 0.68% | 299,775 | Common | SOLE |
| 45258J102 | IMVT | IMMUNOVANT INC | $2.7M | 0.68% | 107,996 | Common | SOLE |
| 019770106 | ALLO | ALLOGENE THERAPEUTICS INC | $2.6M | 0.67% | 1,240,118 | Common | SOLE |
| 92686J106 | VKTX | VIKING THERAPEUTICS INC | $2.6M | 0.66% | 64,516 | Common | SOLE |
| 52886X107 | LXEO | LEXEO THERAPEUTICS INC | $2.6M | 0.66% | 393,083 | Common | SOLE |
| 004397105 | ARAY | ACCURAY INC | $2.4M | 0.62% | 1,222,358 | Common | SOLE |
| 492327101 | KROS | KEROS THERAPEUTICS INC | $2.1M | 0.52% | 130,316 | Common | SOLE |
| 45780L104 | INGN | INOGEN INC | $1.9M | 0.49% | 208,790 | Common | SOLE |
| 86150R107 | STOK | STOKE THERAPEUTICS INC | $1.9M | 0.48% | 171,097 | Common | SOLE |
| 055477103 | BCAX | BICARA THERAPEUTICS INC | $1.8M | 0.47% | 105,500 | Common | SOLE |
| 10501L106 | BWAY | BRAINSWAY LTD | $1.8M | 0.46% | 193,208 | Common | SOLE |
| 603170101 | MLYS | MINERALYS THERAPEUTICS INC | $1.8M | 0.46% | 146,500 | Common | SOLE |
| N44445109 | IMTX | IMMATICS NV | $1.7M | 0.44% | 245,000 | Common | SOLE |
| 014442107 | ALEC | ALECTOR INC | $1.7M | 0.44% | 912,928 | Common | SOLE |
| 15673T100 | IPSC | CENTURY THERAPEUTICS INC | $1.7M | 0.44% | 1,704,232 | Common | SOLE |
| 088786108 | BCYC | BICYCLE THERAPEUTICS PLC | $1.7M | 0.43% | 120,799 | Common | SOLE |
| 46565G104 | 5E7 | ITEOS THERAPEUTICS INC | $1.4M | 0.37% | 188,347 | Common | SOLE |
| 517125100 | LRMR | LARIMAR THERAPEUTICS INC | $1.4M | 0.37% | 371,434 | Common | SOLE |
| 75915K309 | RGLS | REGULUS THERAPEUTICS INC | $1.4M | 0.35% | 875,200 | Common | SOLE |
| 05280R100 | AUTL | AUTOLUS THERAPEUTICS PLC | $1.4M | 0.35% | 586,667 | Common | SOLE |
| 38341P102 | GOSS | GOSSAMER BIO INC | $1.3M | 0.32% | 1,409,262 | Common | SOLE |
| 901384107 | TSVT* | 2SEVENTY BIO INC | $1.3M | 0.32% | 429,252 | Common | SOLE |
| 53566P109 | LCTX | LINEAGE CELL THERAPEUTICS IN | $1.3M | 0.32% | 2,511,374 | Common | SOLE |
| 64135M105 | NGNE | NEUROGENE INC | $1.2M | 0.30% | 51,500 | Common | SOLE |
| M68830112 | MDWD | MEDIWOUND LTD | $1.1M | 0.29% | 64,479 | Common | SOLE |
| 016255101 | ALGN | ALIGN TECHNOLOGY INC | $1.1M | 0.29% | 5,500 | Common | SOLE |
| 09075V102 | BNTX | BIONTECH SE | $968,575 | 0.25% | 8,500 | Common | SOLE |
| 86366E106 | GPCR | STRUCTURE THERAPEUTICS INC | $962,760 | 0.24% | 35,500 | Common | SOLE |
| 82835W108 | SPRY | ARS PHARMACEUTICALS INC | $936,735 | 0.24% | 88,790 | Common | SOLE |
| 20451W101 | CMPS | COMPASS PATHWAYS PLC | $919,334 | 0.23% | 243,210 | Common | SOLE |
| 877619106 | TSHA | TAYSHA GENE THERAPIES INC | $903,925 | 0.23% | 522,500 | Common | SOLE |
| M8001Q126 | PYPD | POLYPID LTD | $885,470 | 0.23% | 291,273 | Common | SOLE |
| 344174107 | FHTX | FOGHORN THERAPEUTICS INC | $881,304 | 0.22% | 186,717 | Common | SOLE |
| 697947109 | PVLA | PALVELLA THERAPEUTICS INC | $857,424 | 0.22% | 71,452 | Common | SOLE |
| 869367102 | — | SUTRO BIOPHARMA INC | $804,225 | 0.20% | 437,079 | Common | SOLE |
| 152309100 | CNTA | CENTESSA PHARMACEUTICALS PLC | $794,838 | 0.20% | 47,453 | Common | SOLE |
| 92764N102 | VIR | VIR BIOTECHNOLOGY INC | $734,000 | 0.19% | 100,000 | Common | SOLE |
| M25722105 | CGEN | COMPUGEN LTD | $684,219 | 0.17% | 447,202 | Common | SOLE |
| 004890109 | ACRV | ACRIVON THERAPEUTICS INC | $676,732 | 0.17% | 112,414 | Common | SOLE |
| 78667J108 | SG7 | SAGE THERAPEUTICS INC | $587,526 | 0.15% | 108,200 | Common | SOLE |
| 007002108 | TORCEUR | ADICET BIO INC | $577,200 | 0.15% | 600,000 | Common | SOLE |
| 574795100 | MASI | MASIMO CORP | $495,900 | 0.13% | 3,000 | Common | SOLE |
| 03843E104 | AQST | AQUESTIVE THERAPEUTICS INC | $452,120 | 0.11% | 127,000 | Common | SOLE |
| 03836J201 | APRE | APREA THERAPEUTICS INC | $451,302 | 0.11% | 137,174 | Common | SOLE |
| H0036K147 | ADCT | ADC THERAPEUTICS SA | $445,921 | 0.11% | 224,081 | Common | SOLE |
| 46489V302 | CATX | PERSPECTIVE THERAPEUTICS INC | $415,239 | 0.11% | 130,169 | Common | SOLE |
| 09203E105 | BDTX | BLACK DIAMOND THERAPEUTICS I | $299,600 | 0.08% | 140,000 | Common | SOLE |
| 09090D301 | — | BIOMX INC | $292,869 | 0.07% | 401,136 | Common | SOLE |
| 00445A100 | — | ACELYRIN INC | $276,285 | 0.07% | 87,989 | Common | SOLE |
| 20454B104 | CMPX | COMPASS THERAPEUTICS INC | $229,671 | 0.06% | 158,394 | Common | SOLE |
| 64157F103 | NVROEUR | NEVRO CORP | $141,360 | 0.04% | 38,000 | Common | SOLE |
| 84833T103 | SPRO | SPERO THERAPEUTICS INC | $128,750 | 0.03% | 125,000 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.